This page includes the latest FDA filings for Nextsource Biotechnology L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Nextsource Biotechnology LLC, Huons Co., Ltd. | Prescription Medication | 2024-09-26 |
Nextsource Biotechnology LLC, Huons Co., Ltd. | Prescription Medication | 2024-09-21 |
NextSource Biotechnology, LLC | Prescription Medication | 2024-03-05 |
NextSource Biotechnology, LLC | Prescription Medication | 2023-03-31 |
NextSource Biotechnology, LLC | Prescription Medication | 2020-11-12 |
NextSource Biotechnology, LLC | Prescription Medication | 2019-12-21 |
NextSource Biotechnology, LLC | Prescription Medication | 2018-09-12 |
NextSource Biotechnology, LLC | Gleostine | 2014-08-18 |
NextSource Biotechnology, LLC | Gleostine | 2014-08-18 |
NextSource Biotechnology, LLC | Gleostine | 2014-08-18 |
NCAGE Code | 735E8 | NEXTSOURCE BIOTECHNOLOGY LLC |
CAGE Code | 735E8 | NEXTSOURCE BIOTECHNOLOGY LLC |
Import ID | Shipment | Cargo Description | Quantity |
---|---|---|---|
2020080424042 | Napoli,Italy -> Miami, Florida | PHARMACEUTICAL HS 300490 GLEOSTINE CAP 10MG 1BTLX5 GLEOSTINE CAP 100MG 1BTLX5 USA TEMP.SET TO +20C | 3 PKG |
2020080145527 | Napoli,Italy -> Miami, Florida | PHARMACEUTICAL HS 300490 GLEOSTINE CAP 10MG 1BTLX5 GLEOSTINE CAP 100MG 1BTLX5 USA TEMP.SET TO +20C | 3 PKG |
2020070424075 | Napoli,Italy -> Miami, Florida | PHARMACEUTICAL HS 300490 GLEOSTINE CAP 40MG 1BTLX5 USA TEMP.SET TO +20C | 2 PKG |